Kolexia
Azais Isabelle Rhumatologie
Azais Isabelle
Rhumatologie
Hôpital La Miletrie
Poitiers, France
46 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Myélome multiple Tumeurs à plasmocytes Gammapathie monoclonale de signification indéterminée Aberrations des chromosomes Maladies osseuses Plasmocytome Ostéolyse Thromboembolie Paraprotéinémies

Collaborateurs

Voir plus
Durand Geraldine
Durand Geraldine
Hôpital La Miletrie, Poitiers, France
Leleu Xavier
Leleu Xavier
Hôpital La Miletrie, Poitiers, France
Debiais Francoise
Debiais Francoise
Hôpital La Miletrie, Poitiers, France
Brault Rachel
Brault Rachel
Hôpital La Miletrie, Poitiers, France

Industries

Voir plus
Biogen
1 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
American journal of hematology   01 janvier 2023
Erratum to "Comparison of whole-body diffusion MRI andconventional radiological assessment in the staging of myeloma" Diagn. Interv. Imaging. 94 (2013), 629-636.
Diagnostic and interventional imaging   22 avril 2020
Profile of Long-Term Survivors in Multiple Myeloma
Blood   13 novembre 2019
FIRST: A Phase III, Randomized, Open-label, 3-arm Study to Determine the Efficacy and Safety of Lenalidomide(REVLIMID) Plus Low-dose Dexamethasone When Given Until Progressive Disease or for 18 Four-week Cycles Versus the Combination of Melphalan, Prednisone, and Thalidomide Given for 12 Six-week Cycles in Patients With Previously Untreated Multiple Myeloma Who Are Either 65 Years of Age or Older or Not Candidates for Stem Cell Transplantation.
Essai Clinique (Celgene)   07 novembre 2019
Pomalidomide 3rd line versus 4th line for in Early Relapsed Refractory Multiple Myeloma
17th International Myeloma Workshop   01 octobre 2019
Weekly 20/56mg/m2 Carfilzomib, Lenalidomide and Dexamethasone until progression in Early Relapsed Refractory Multiple Myeloma
17th International Myeloma Workshop   01 octobre 2019
Weekly 20/56 mg/m² carfilzomib, lenalidomide, and dexamethasone until progression in early relapsed refractory multiple myeloma.
2019 ASCO Annual Meeting I   26 mai 2019
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.
Leukemia   09 avril 2019
Chronic HCV Infection and Autologous Stem Cell Transplantation for Multiple Myeloma
Blood   29 novembre 2018
Carfilzomib Weekly 20/56mg/m², Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma
Blood   29 novembre 2018